You are currently accessing the institutional-grade blueprint for <b>Geriatric Pharmacology: Tools for the Healthcare Professional – Steven Atkinson</b>. Instant digital deployment and lifetime encrypted access are guaranteed immediately upon transaction clearance.
2 Hours 01 Minutes
For geriatric patients taking more than five medications, the statistical chance of a drug-drug interaction or adverse event is 100%! For those experiencing an adverse drug event, one third will require additional treatment. This session will provide straightforward tools that will help you care for older adults receiving multiple medications.
Purchase Geriatric Pharmacology: Tools for the Healthcare Professional – Steven Atkinson courses at here with PRICE $59.99 $35
For geriatric patients taking more than five medications, the statistical chance of a drug-drug interaction or adverse event is 100%! For those experiencing an adverse drug event, one third will require additional treatment. This session will provide straightforward tools that will help you care for older adults receiving multiple medications.
- Apply techniques and identify strategies to avoid adverse drug events and drug disease interactions.
- Develop individualized monitoring plans for geriatric patients through the evaluation of high risk medications.
- Identify at least three new guideline recommendations related to geriatric pharmacology
- Drug Utilization Amongst the Elderly
- Billing Codes That You MUST Know
- Clinical Pharmacological Issues in the Elderly
Tag: Geriatric Pharmacology: Tools for the Healthcare Professional – Steven Atkinson Review. Geriatric Pharmacology: Tools for the Healthcare Professional – Steven Atkinson download. Geriatric Pharmacology: Tools for the Healthcare Professional – Steven Atkinson discount.
Purchase Geriatric Pharmacology: Tools for the Healthcare Professional – Steven Atkinson courses at here with PRICE $59.99 $35
Trading foreign exchange, cryptocurrencies, and algorithmic assets on margin carries a high level of risk and may not be suitable for all investors. Past performance of any trading system or quantitative blueprint does not guarantee future results.<br><br><b>Asset Classification:</b>

